B P International

Plasmacytoma One of the manifestations of plasma cell dyscrasia is neoplastic proliferation of plasma cells, which can appear as multiple myeloma, primary amyloidosis, or monoclonal gammopathy of uncertain significance. A number of factors have been identified, including viral pathogenesis and irritation from breathed irritants. Although genetic factors may play a role, no particular loci for the disease's origin have been found. Plasmacytoma primarily affects persons in their fifth and sixth decades of life. The International Myeloma Working Group's (IMWG) diagnostic criteria for SP state that the lesion must be solitary in character with no clinical, radiological, or biochemical indications of systemic involvement. Author (S) Details Satish Deshmukh Department of General Surgery, NKP Salve Institute of Medical Sciences and Research Centre, Nagpur, Maharashtra, India. Sushrut. M. Fulare Department of General Surgery, NKP Salve Institute of Medical Sciences and Researc...

Multiple myeloma (MM) is a physiologically heterogeneous illness characterised by a wide range of chromosomal, genetic, and epigenetic alterations. Without affecting the DNA sequence, epigenetic changes can influence gene function. DNA methylation and post-translational alteration of histone proteins (histone methylation, acetylation, and deacetylation) are two biochemical modifications that have a role in the pathogenesis of MM. Epigenetic DNA methyltransferases (DNMTs), ten-eleven translocation enzymes (TET), histone acetyltransferases (HATs), and histone deacetylases are examples of key specialised enzymatic entities that mediate changes (HDACs). Micro-RNA molecules have a role in epigenetic processes as part of a complicated machinery. Not only does epigenetics play a role in myeloma genesis, but it also has an impact on medication resistance and prognosis in individuals with MM. Author(s) Details Flodrova Pavla Department of Clinical and Molecular Pathology, Faculty of Me...